Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-01-02 @ 3:19 PM
Study NCT ID:
NCT00072267
Status:
COMPLETED
Last Update Posted:
2015-07-23
First Post:
2003-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
University Health Network, Toronto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-01
Start Date Type:
None
Primary Completion Date:
2005-04
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2003-11-04
First Submit QC Date:
None
Study First Post Date:
2003-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-22
Last Update Post Date:
2015-07-23
Last Update Post Date Type:
ESTIMATED